Ergomed (ERGO LN)

Analysis

Health Care • United Kingdom

Ergomed provides specialized services to the pharmaceutical and biotechnology industries, focusing on clinical development, trial management, and pharmacovigilance. The company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV), offering solutions for all phases of clinical trials and post-approval drug safety. Ergomed was founded in 1997 and is headquartered in Guildford, United Kingdom.

Refresh

Company Presentation • 21 Mar 2023 16:30

H2 2022

Company Presentation • 27 Sep 2022 16:30

H1 2022

Company Presentation • 09 Feb 2022 17:35

M&A Announcement

Company Presentation • 29 Mar 2022 16:32

H2 2021

Company Presentation • 28 Sep 2021 16:28

H1 2021

No more presentations

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00